Market Research Report
Kinase Inhibitors - Global Market Outlook (2019-2027)
|Published by||Stratistics Market Research Consulting||Product code||942479|
|Published||Content info||160 Pages
Delivery time: 2-3 business days
|Kinase Inhibitors - Global Market Outlook (2019-2027)|
|Published: June 1, 2020||Content info: 160 Pages||
According to Stratistics MRC, the Global Kinase Inhibitors Market is accounted for $40.41 billion in 2019 and is expected to reach $64.90 billion by 2027 growing at a CAGR of 6.1% during the forecast period. Some of the key factors propelling the market growth include rise in awareness about kinase inhibitors, surge in product approvals, increase in incident of cancer diseases, and increase in investment from pharmaceutical companies. However, cost of treatment and lack of funds in conducting research are likely to restraint the market. In addition, increase in adoption of kinase inhibitors for newer applications, and emerging economies such as China, India and others, will create new opportunities for global kinase inhibitors market.
Kinase inhibitors are considered as specific enzymes that help in preventing the process of cell division and the growth of cancerous cells. These inhibitors are easy to use and are handy while treating cancer patients by blocking the signals that alert the cancer cells to grow. With the help of research and development activities in the cancer treatments, several innovations, and advanced therapeutics have been introduced. However, the results of these drugs and treatments are considered partial, palliative, and unpredictable at times. Kinase inhibitors are being highly publicized as a potential treatment for alopecia areata (AA).
By application, the oncology segment is expected to grow at the significant rate during the forecast period. Large number of approved drugs along with rich product pipeline for cancer treatment is anticipated to fuel the growth of the segment in the near future. Based on data from clinicaltrials.gov last updated on January 2020, over 75 kinase inhibitor drugs are in various phases of clinical trials for the application of oncology. On the basis of geography, North America is anticipated to have considerable market growth during the forecast period, due to rise in awareness about new drugs for treatment, availability of all major companies in the region, the introduction of new drugs, and high prevalence of cases in U.S.
Some of the key players in kinase inhibitors market include Меrсk ?еrоnо ?а, Nоvаrt?? ?ntеrnаt?оnаl Аg, Incyte Corporation, Glaxo SmithKline, Суtrх Соrроrаt?оn, О?? Рhаrmасеut?саl? Llс, AstraZeneca, Eisai Co., Ltd., Bristol-Myers Squibb, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Eisai Co., Ltd., Johnson & Johnson, Еtоn В?о?с?еnсе ?nс., and F. Hoffmann-La Roche Ltd.
Distribution Channels Covered:
End Users Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.